W. Herr

1.5k total citations
32 papers, 846 citations indexed

About

W. Herr is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, W. Herr has authored 32 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in W. Herr's work include Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). W. Herr is often cited by papers focused on Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). W. Herr collaborates with scholars based in Germany, United States and Switzerland. W. Herr's co-authors include Simone Thomas, Udo F. Hartwig, Matthias Theobald, Ralf G. Meyer, Christian G. Huber, Ulrich Moebius, Carmen Scheibenbogen, Ulrich Keilholz, H-G Rammensee and Stephanie Mayer and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Journal of Virology.

In The Last Decade

W. Herr

31 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Herr Germany	19	507	282	225	194	192	32	846
Patrick Squiban France	15	452 0.9×	296 1.0×	154 0.7×	322 1.7×	126 0.7×	33	970
Roelof A. de Paus Netherlands	16	627 1.2×	274 1.0×	126 0.6×	173 0.9×	201 1.0×	27	923
Paul Sims United States	10	247 0.5×	105 0.4×	119 0.5×	317 1.6×	100 0.5×	14	762
Jeong-Hee Lee South Korea	9	1.1k 2.1×	106 0.4×	104 0.5×	137 0.7×	135 0.7×	19	1.4k
L Gemmell United States	9	523 1.0×	204 0.7×	230 1.0×	238 1.2×	94 0.5×	10	995
Dário Ligeiro Portugal	17	440 0.9×	134 0.5×	108 0.5×	371 1.9×	90 0.5×	47	895
Benoît Vingert France	17	460 0.9×	77 0.3×	224 1.0×	155 0.8×	146 0.8×	39	916
Matteo Giovanni Carrabba Italy	15	661 1.3×	435 1.5×	266 1.2×	412 2.1×	116 0.6×	48	1.1k
S. G. E. Marsh United Kingdom	11	733 1.4×	92 0.3×	126 0.6×	158 0.8×	138 0.7×	35	966
Geert C. Mudde Austria	24	830 1.6×	116 0.4×	80 0.4×	422 2.2×	155 0.8×	62	1.8k

Countries citing papers authored by W. Herr

Since Specialization

Citations

This map shows the geographic impact of W. Herr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Herr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Herr more than expected).

Fields of papers citing papers by W. Herr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Herr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Herr. The network helps show where W. Herr may publish in the future.

Co-authorship network of co-authors of W. Herr

This figure shows the co-authorship network connecting the top 25 collaborators of W. Herr. A scholar is included among the top collaborators of W. Herr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Herr. W. Herr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menhart, Karin, Dennis Christoph Harrer, W. Herr, et al.. (2024). Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab. Frontiers in Pharmacology. 15. 1334233–1334233. 1 indexed citations

Lamby, P., Daniel Wolff, Stephan Mielke, et al.. (2019). Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients. Annals of Hematology. 98(8). 1867–1875. 4 indexed citations

Walter, Ingrid, Ulrike Schulz, Martin Vogelhuber, et al.. (2017). Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. Medical Oncology. 34(12). 192–192. 24 indexed citations

Weber, Daniela, Peter J. Oefner, Katja Dettmer, et al.. (2016). Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(8). 1087–1092. 86 indexed citations

Holler, Barbara, Daniela Weber, Ernst Holler, et al.. (2016). Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset. Annals of Hematology. 96(2). 299–310. 19 indexed citations

Herr, W., et al.. (2016). HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia. 31(2). 434–445. 26 indexed citations

Vogelhuber, Martin, Susan Feyerabend, Arnulf Stenzl, et al.. (2014). Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. Cancer Microenvironment. 8(1). 33–41. 12 indexed citations

Teschner, Daniel, et al.. (2013). Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis. Bone Marrow Transplantation. 49(1). 138–144. 66 indexed citations

Frey, Mark R., et al.. (2011). Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells. Haematologica. 96(7). 1024–1032. 53 indexed citations

10.

Kleemann, P. P., Simone Thomas, Sebastian Klobuch, et al.. (2011). Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation. Haematologica. 97(6). 874–882. 19 indexed citations

11.

Baumann, Daniela, David Strand, Ralf G. Meyer, et al.. (2010). Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles. Biomaterials. 31(27). 7086–7095. 20 indexed citations

12.

Meyer, Ralf G., Eva Wagner, Abdo Konur, et al.. (2009). Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation. Bone Marrow Transplantation. 45(4). 668–674. 13 indexed citations

13.

Schuchmann, M., Ralf G. Meyer, Esther von Stebut, et al.. (2008). The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation. American Journal of Transplantation. 8(11). 2434–2444. 16 indexed citations

14.

Atreya, Imke, C Schimanski, Christoph Becker, et al.. (2007). The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut. 56(11). 1572–1578. 32 indexed citations

15.

Penack, Olaf, Lars Fischer, Andrea Stroux, et al.. (2007). Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation. Bone Marrow Transplantation. 41(4). 377–383. 18 indexed citations

16.

Hartwig, Udo F., Marion Nonn, Shahida Khan, et al.. (2005). Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplantation. 37(3). 297–305. 51 indexed citations

17.

Kuball, Jürgen, Martin Schüler, Edite Antunes Ferreira, et al.. (2002). Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man. Gene Therapy. 9(13). 833–843. 47 indexed citations

18.

Heike, Michael, JF Schlaak, Henning Schulze‐Bergkamen, et al.. (1996). Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens. The Journal of Immunology. 156(6). 2205–2213. 18 indexed citations

19.

Herr, W., Andreas Schwarting, Bianca M. Wittig, et al.. (1994). Enormous hemangiosarcoma of the heart. Journal of Molecular Medicine. 72(5). 372–6. 2 indexed citations

20.

Herr, W., Guido Gerken, T. Poralla, et al.. (1993). Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver. Journal of Molecular Medicine. 71(1). 49–53. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact